GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aravive Inc (STU:VE11) » Definitions » Other Gross PPE

Aravive (STU:VE11) Other Gross PPE : €1.01 Mil (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Aravive Other Gross PPE?

Aravive's Other Gross PPE for the quarter that ended in Sep. 2023 was €1.01 Mil.

Aravive's quarterly Other Gross PPE declined from Mar. 2023 (€1.42 Mil) to Jun. 2023 (€1.20 Mil) and declined from Jun. 2023 (€1.20 Mil) to Sep. 2023 (€1.01 Mil).

Aravive's annual Other Gross PPE declined from Dec. 2020 (€4.63 Mil) to Dec. 2021 (€4.32 Mil) and declined from Dec. 2021 (€4.32 Mil) to Dec. 2022 (€3.90 Mil).


Aravive Other Gross PPE Historical Data

The historical data trend for Aravive's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aravive Other Gross PPE Chart

Aravive Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 10.23 4.63 4.32 3.90

Aravive Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.96 3.90 1.42 1.20 1.01

Aravive Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Aravive Business Description

Traded in Other Exchanges
N/A
Address
3730 Kirby Drive, River Oaks Tower, Suite 1200, Houston, TX, USA, 77098
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.

Aravive Headlines

No Headlines